Literature DB >> 25863941

Key issues in addressing the comorbidity of depression and pediatric epilepsy.

Jay A Salpekar1, Gaurav Mishra2, Aaron J Hauptman3.   

Abstract

Depression is a common comorbidity associated with epilepsy. However, the etiology of depression is difficult to establish given the heterogeneity in both epilepsy and depression. Nevertheless, the co-occurrence is so common that a bidirectional relationship between depression and epilepsy has been theorized. Persons with temporal lobe seizure foci and partial-onset epilepsy may be more vulnerable to the development of depression. In pediatrics, depression differs but may be readily identified by understanding nuances of mood states and variability of neurovegetative symptom presentation. Although no clear treatment guidance exists in the context of epilepsy, antidepressants have been relatively well studied in pediatrics and are effective and well tolerated. Anticonvulsant drugs may also improve depressive symptoms though clinical research is lacking in pediatrics. Treatment of depression may independently improve outcome for epilepsy and for quality of life. Future studies will clarify etiologies of depression in the context of epilepsy and improve the evidence base for treatment outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Diagnosis; Epilepsy; Pediatrics; Treatment

Mesh:

Year:  2015        PMID: 25863941     DOI: 10.1016/j.yebeh.2015.02.036

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Depression Screening Tools: More Hammers, Fewer Nails.

Authors:  Jay Salpekar
Journal:  Epilepsy Curr       Date:  2018 Jan-Feb       Impact factor: 7.500

Review 2.  [Depression and epilepsy : Two clinical pictures with common causes?].

Authors:  M Borgmann; M Holtkamp; M Adli; J Behr
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

Review 3.  Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities.

Authors:  Fan Chen; Xinghui He; Guoming Luan; Tianfu Li
Journal:  Front Neurol       Date:  2019-02-26       Impact factor: 4.003

4.  Effect of Long-Term Treatment with Vagus Nerve Stimulation on Mood and Quality of Life in Korean Patients with Drug-Resistant Epilepsy.

Authors:  Jeong Sik Kim; Dong Yeop Kim; Hyun Jin Jo; Yoon Ha Hwang; Joo Yeon Song; Kwang Ik Yang; Seung Bong Hong
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.